Neoadjuvant Chemotherapy Alters Exhaustion of CD4+ and CD8+ T Cells in HER2-Overexpressing Metastatic Breast Cancer
Journal of Current Oncological Trends · 2025
DOI: 10.4103/jcot.jcot_15_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Oncological Trends, 2025. Verfasst von Ananya Das und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Human epidermal growth factor 2 overexpressing breast cancer (HER2 high BCa) accounts for 20%–25% of all other BCa subtypes. Despite multimodal therapeutic approaches, trastuzumab and docetaxel (TD) as neoadjuvant chemotherapy (NACT) showed poor disease prognosis with a high recurrence rate in HER2 high metastatic BCa (MBCa).
Aims
The influence of NACT on intratumoral and peripheral T cells in HER2 high MBCa needs an in-depth understanding. This study aims to evaluate the effect of NACT on T cells to identify the underlying mechanisms of disease progression of HER2 high MBCa. Materials and Methods: Thirty-eight metastatic HER2 high BCa samples were included in this study. H and E staining and IHC were performed in NACT and primary HER2 high MBCa to assess tumor-infiltrating lymphocytes count and exhaustion marker expression, respectively. Single cells were obtained from tumor to analyse the exhaustion profile of CD4+ and CD8+ T cells by flow cytometry. ELISA analysis was performed on the serum to validate the cytokine expressions.
Results
GEO dataset analysis showed higher expression of programmed cell death protein l, programmed cell death ligand 1 (PDL-1), lymphocyte-associated gene 3 (LAG-3), and CTLA-4 in HER2 high BCa compared with HER2 low BCa cases. Moreover, lower expression of programmed cell death protein l, PDL-1, and LAG-3 was associated with better survival. Importantly, flow cytometry analysis revealed that NACT downregulated the exhausted and conventional CD4+ and CD8+ T cells in the intratumoral and peripheral region of HER2 high MBCa.
Conclusion
NACT downregulated both functional and exhausted T cells in HER2 high MBCa, which suggests that NACT induced immunosuppression in HER2 high MBCa. Therefore, considering immunotherapy with NACT could be proven as a novel therapeutic approach for better survival of HER2 high MBCa.
Zitieren
APA
Das, A., Roy, S., Bairagi, A., Alam, N., & Chatterjee, N. (2025). Neoadjuvant Chemotherapy Alters Exhaustion of CD4+ and CD8+ T Cells in HER2-Overexpressing Metastatic Breast Cancer. Journal of Current Oncological Trends. https://doi.org/10.4103/jcot.jcot_15_25
Vancouver
Das A, Roy S, Bairagi A, Alam N, Chatterjee N. Neoadjuvant Chemotherapy Alters Exhaustion of CD4+ and CD8+ T Cells in HER2-Overexpressing Metastatic Breast Cancer. Journal of Current Oncological Trends. 2025. doi:10.4103/jcot.jcot_15_25
BibTeX
@article{Das2025,
author = {Das, Ananya and Roy, Sraddhya and Bairagi, Aparajita and Alam, Neyaz and Chatterjee, Nabanita},
title = {Neoadjuvant Chemotherapy Alters Exhaustion of CD4+ and CD8+ T Cells in HER2-Overexpressing Metastatic Breast Cancer},
journal = {Journal of Current Oncological Trends},
year = {2025},
doi = {10.4103/jcot.jcot_15_25}
}
EUVIMED